SEC Comment Letter 0000000000-23-008045 to BIOLASE, INC (BIOL) (CIK 0000811240)
BIOLASE, INC (BIOL) (CIK 0000811240)
Date: July 27, 2023 · CIK: 0000811240 · Accession: 0000000000-23-008045
AI Filing Summary & Sentiment
File numbers found in text: 333-273372
Letter
United States securities and exchange commission logo July 27, 2023 John Beaver Chief Executive Officer Biolase, Inc. 27042 Towne Centre Drive, Suite 270 Lake Forest, California 92610 Re:Biolase, Inc. Registration Statement on Form S-1 Filed July 21, 2023 File No. 333-273372 Dear John Beaver: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jane Park at 202-551-7439 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Leslie Marlow, Esq.
Show Raw Text
United States securities and exchange commission logo
July 27, 2023
John Beaver
Chief Executive Officer
Biolase, Inc.
27042 Towne Centre Drive, Suite 270
Lake Forest, California 92610
Re:Biolase, Inc.
Registration Statement on Form S-1
Filed July 21, 2023
File No. 333-273372
Dear John Beaver:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jane Park at 202-551-7439 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Leslie Marlow, Esq.